About: A two-stage Bayesian design with sample size reestimation and subgroup analysis for phase II binary response trials

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A two-stage Bayesian design with sample size reestimation and subgroup analysis for phase II binary response trials Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 11 April 2013

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) artículu científicu espublizáu en 2013 (ast) наукова стаття, опублікована у квітні 2013 (uk) 2013 թվականի ապրիլի 11-ին հրատարակված գիտական հոդված (hy) scientific article published on 11 April 2013 (en) مقالة علمية نشرت في 11 أبريل 2013 (ar)
publication date	wds:Q37131837-C31E619C-9AFE-4E80-9B7B-3B2A66C29ADF
publication date	2013-04-11 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37131837-2B036AAE-7C8F-4D10-B484-1787399DCD52
language of work or name	English
cites work	wds:Q37131837-07B36600-CCAF-40EA-AA1B-72448F35277D wds:Q37131837-099F2761-B492-4140-A158-D06D872F104E wds:Q37131837-19ACA41A-41E0-4EC4-BAB8-8EF4ED994C69 wds:Q37131837-19BE64B4-DB15-4AB8-8999-5CC790E22812 wds:Q37131837-29CFE16F-E80C-4B4B-B784-EDA547F002B7 wds:Q37131837-4A2275AB-18B5-472F-B5A7-1CC6F6CE5C5D wds:Q37131837-5641AC83-A87F-44B6-A29B-CF40C414A69A wds:Q37131837-627E746B-B493-4FCE-8A9B-EB2D6E260ACE wds:Q37131837-70BB9032-B48E-4A6B-9C26-6249AA55EA74 wds:Q37131837-79D3853E-714F-4CEB-A8F4-0928B3F59892 wds:Q37131837-7ADCE001-D7C7-488B-9CC6-0E1B08AA6E95 wds:Q37131837-8FA00063-6BCB-4B86-A7B6-88F732A4B27D wds:Q37131837-9A982E7A-3D64-44D5-B9EA-E819D68FF029 wds:Q37131837-A5408528-A700-41D5-8836-D0AF4FBB360E wds:Q37131837-B4184F7F-9B83-4169-A0FF-EB0D7B1DC09B wds:Q37131837-DF5BBA57-EB28-4812-80C8-3FEFAFC3DDD3 wds:Q37131837-E55FCA68-EB20-4A8B-BEA9-C617FCF9EADE
cites work	Optimal two-stage designs for phase II clinical trials Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. Does comparative-effectiveness research threaten personalized medicine? The prospects for "personalized medicine" in drug development and drug therapy Bayesian techniques for sample size determination in clinical trials: a short review Sample size reestimation by Bayesian prediction Design for sample size re-estimation with interim data for double-blind clinical trials with binary outcomes Projection from previous studies: a Bayesian and frequentist compromise A predictive approach to selecting the size of a clinical trial, based on subjective clinical opinion Sample size determination for phase II clinical trials based on Bayesian decision theory. Applying Bayesian ideas in drug development and clinical trials. Sample size re-estimation: recent developments and practical considerations. Bayesian sample size for exploratory clinical trials incorporating historical data Sample size determinants for r X c comparative trials The determinatio of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent Sample size recalculation using conditional power. Symmetric group sequential test designs
author name string	wds:Q37131837-16772179-458D-412C-822F-1F8755101435 wds:Q37131837-8ED18661-2DC8-4EF0-8F66-C7A9B3D6F599
author name string	Joseph S Koopmeiners Wei Zhong
rdfs:label	A two-stage Bayesian design with sample size reestimation and subgroup analysis for phase II binary response trials (en) A two-stage Bayesian design with sample size reestimation and subgroup analysis for phase II binary response trials (nl) A two-stage Bayesian design with sample size reestimation and subgroup analysis for phase II binary response trials (ast)
skos:prefLabel	A two-stage Bayesian design with sample size reestimation and subgroup analysis for phase II binary response trials (en) A two-stage Bayesian design with sample size reestimation and subgroup analysis for phase II binary response trials (nl) A two-stage Bayesian design with sample size reestimation and subgroup analysis for phase II binary response trials (ast)
name	A two-stage Bayesian design with sample size reestimation and subgroup analysis for phase II binary response trials (en) A two-stage Bayesian design with sample size reestimation and subgroup analysis for phase II binary response trials (nl) A two-stage Bayesian design with sample size reestimation and subgroup analysis for phase II binary response trials (ast)
author	wds:Q37131837-EB12DD35-899C-45A6-82A9-ABA6C9EAA719
author	Bradley P. Carlin
title	wds:Q37131837-8BCEB54D-2839-4DCC-B664-AAB00243B56F
title	A two-stage Bayesian design with sample size reestimation and subgroup analysis for phase II binary response trials (en)
page(s)	wds:Q37131837-2F1E4483-2DC5-4B79-91E7-2F89198BCB68
page(s)	587-596
instance of	wds:Q37131837-AF18723D-F348-4415-BFAE-E618B1FB7DA7
instance of	scholarly article
main subject	wds:Q37131837-BC13373B-A4EE-4481-8285-71F9F0CB1A96
main subject	phase II clinical trial
PubMed ID	wds:Q37131837-002407BC-E4E7-4F4E-B5BC-0E8D2B85A9E9
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/23583925
PubMed ID	23583925
published in	wds:Q37131837-A8C19711-06E5-424A-A539-15D002CA3A83
published in	Contemporary Clinical Trials
issue	wds:Q37131837-E83D5771-9905-45E1-96A0-A8AA81EC465F
volume	wds:Q37131837-702ADD26-C68B-4036-B926-51E05D27A6D1
issue	2
volume	36
DOI	wds:Q37131837-752DD79B-B50C-49A1-9DA2-C56F5D387034
DOI	http://dx.doi.org/10.1016/J.CCT.2013.03.011
DOI	10.1016/J.CCT.2013.03.011
PMCID	wds:Q37131837-B493312D-9299-43D3-BABA-C31F6DAAFC54
PMCID	3757106
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q37131837
is cites work of	Methods for identification and confirmation of targeted subgroups in clinical trials: A systematic review Bayesian approach to estimate AUC, partition coefficient and drug targeting index for studies with serial sacrifice design Bayesian design for two-arm randomized Phase II clinical trials with endpoints from the exponential family using multiple constraints. A randomized two-stage design for phase II clinical trials based on a Bayesian predictive approach
is cites work of	wds:Q37620062-A484D38D-5633-4414-8FE1-DEC632C58D64 wds:Q49665167-C1C79782-0C59-4F59-80F7-C993DF27EC03

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software